The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Cell therapy Processing-Global Market Insights and Sales Trends 2025
Synopsis
The global Cell therapy Processing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cell therapy Processing in various end use industries. The expanding demands from the Cardiovascular Disease, Bone Repair, Neurological Disorders and Skeletal Muscle RepairImmune Diseases, are propelling Cell therapy Processing market. Products, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Services segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Cell therapy Processing market, driven by demand from China, the second largest economy with some signs of stabilising, the Cell therapy Processing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cell therapy Processing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cell therapy Processing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cell therapy Processing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cell therapy Processing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cell therapy Processing covered in this report include Anthrogenesis Corp., BioNTech, Cell Ideas, Epic Sciences, Roche, FuGENE, IBC Pharmaceuticals Inc., Bluebird Bio Inc. and Immodulon-Therapeutics, etc.
The global Cell therapy Processing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Anthrogenesis Corp.
BioNTech
Cell Ideas
Epic Sciences
Roche
FuGENE
IBC Pharmaceuticals Inc.
Bluebird Bio Inc.
Immodulon-Therapeutics
Immunomedics Inc.
Juno Therapeutics Inc.
Medlmmune Inc.
NeoStem Oncology
Neurotech USA
Novartis
Persimmune Inc.
Pluristem Therapeutics
BioMed Valley Discoveries Inc.
Regeneron Pharmaceuticals Inc.
UCL Business PLC.
Global Cell therapy Processing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cell therapy Processing market, Segment by Type:
Products
Services
Software
Global Cell therapy Processing market, by Application
Cardiovascular Disease
Bone Repair
Neurological Disorders
Skeletal Muscle RepairImmune Diseases
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cell therapy Processing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Cell therapy Processing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cell therapy Processing in various end use industries. The expanding demands from the Cardiovascular Disease, Bone Repair, Neurological Disorders and Skeletal Muscle RepairImmune Diseases, are propelling Cell therapy Processing market. Products, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Services segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Cell therapy Processing market, driven by demand from China, the second largest economy with some signs of stabilising, the Cell therapy Processing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cell therapy Processing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cell therapy Processing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cell therapy Processing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cell therapy Processing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cell therapy Processing covered in this report include Anthrogenesis Corp., BioNTech, Cell Ideas, Epic Sciences, Roche, FuGENE, IBC Pharmaceuticals Inc., Bluebird Bio Inc. and Immodulon-Therapeutics, etc.
The global Cell therapy Processing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Anthrogenesis Corp.
BioNTech
Cell Ideas
Epic Sciences
Roche
FuGENE
IBC Pharmaceuticals Inc.
Bluebird Bio Inc.
Immodulon-Therapeutics
Immunomedics Inc.
Juno Therapeutics Inc.
Medlmmune Inc.
NeoStem Oncology
Neurotech USA
Novartis
Persimmune Inc.
Pluristem Therapeutics
BioMed Valley Discoveries Inc.
Regeneron Pharmaceuticals Inc.
UCL Business PLC.
Global Cell therapy Processing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cell therapy Processing market, Segment by Type:
Products
Services
Software
Global Cell therapy Processing market, by Application
Cardiovascular Disease
Bone Repair
Neurological Disorders
Skeletal Muscle RepairImmune Diseases
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cell therapy Processing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Cell therapy Processing
1.1 Cell therapy Processing Market Overview
1.1.1 Cell therapy Processing Product Scope
1.1.2 Cell therapy Processing Market Status and Outlook
1.2 Global Cell therapy Processing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Cell therapy Processing Market Size by Region (2018-2029)
1.4 Global Cell therapy Processing Historic Market Size by Region (2018-2023)
1.5 Global Cell therapy Processing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Cell therapy Processing Market Size (2018-2029)
1.6.1 North America Cell therapy Processing Market Size (2018-2029)
1.6.2 Europe Cell therapy Processing Market Size (2018-2029)
1.6.3 Asia-Pacific Cell therapy Processing Market Size (2018-2029)
1.6.4 Latin America Cell therapy Processing Market Size (2018-2029)
1.6.5 Middle East & Africa Cell therapy Processing Market Size (2018-2029)
2 Cell therapy Processing Market by Type
2.1 Introduction
2.1.1 Products
2.1.2 Services
2.1.3 Software
2.2 Global Cell therapy Processing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Cell therapy Processing Historic Market Size by Type (2018-2023)
2.2.2 Global Cell therapy Processing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Cell therapy Processing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Cell therapy Processing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Cell therapy Processing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Cell therapy Processing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Cell therapy Processing Revenue Breakdown by Type (2018-2029)
3 Cell therapy Processing Market Overview by Application
3.1 Introduction
3.1.1 Cardiovascular Disease
3.1.2 Bone Repair
3.1.3 Neurological Disorders
3.1.4 Skeletal Muscle RepairImmune Diseases
3.2 Global Cell therapy Processing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Cell therapy Processing Historic Market Size by Application (2018-2023)
3.2.2 Global Cell therapy Processing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Cell therapy Processing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Cell therapy Processing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Cell therapy Processing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Cell therapy Processing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Cell therapy Processing Revenue Breakdown by Application (2018-2029)
4 Cell therapy Processing Competition Analysis by Players
4.1 Global Cell therapy Processing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cell therapy Processing as of 2022)
4.3 Date of Key Players Enter into Cell therapy Processing Market
4.4 Global Top Players Cell therapy Processing Headquarters and Area Served
4.5 Key Players Cell therapy Processing Product Solution and Service
4.6 Competitive Status
4.6.1 Cell therapy Processing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Anthrogenesis Corp.
5.1.1 Anthrogenesis Corp. Profile
5.1.2 Anthrogenesis Corp. Main Business
5.1.3 Anthrogenesis Corp. Cell therapy Processing Products, Services and Solutions
5.1.4 Anthrogenesis Corp. Cell therapy Processing Revenue (US$ Million) & (2018-2023)
5.1.5 Anthrogenesis Corp. Recent Developments
5.2 BioNTech
5.2.1 BioNTech Profile
5.2.2 BioNTech Main Business
5.2.3 BioNTech Cell therapy Processing Products, Services and Solutions
5.2.4 BioNTech Cell therapy Processing Revenue (US$ Million) & (2018-2023)
5.2.5 BioNTech Recent Developments
5.3 Cell Ideas
5.3.1 Cell Ideas Profile
5.3.2 Cell Ideas Main Business
5.3.3 Cell Ideas Cell therapy Processing Products, Services and Solutions
5.3.4 Cell Ideas Cell therapy Processing Revenue (US$ Million) & (2018-2023)
5.3.5 Epic Sciences Recent Developments
5.4 Epic Sciences
5.4.1 Epic Sciences Profile
5.4.2 Epic Sciences Main Business
5.4.3 Epic Sciences Cell therapy Processing Products, Services and Solutions
5.4.4 Epic Sciences Cell therapy Processing Revenue (US$ Million) & (2018-2023)
5.4.5 Epic Sciences Recent Developments
5.5 Roche
5.5.1 Roche Profile
5.5.2 Roche Main Business
5.5.3 Roche Cell therapy Processing Products, Services and Solutions
5.5.4 Roche Cell therapy Processing Revenue (US$ Million) & (2018-2023)
5.5.5 Roche Recent Developments
5.6 FuGENE
5.6.1 FuGENE Profile
5.6.2 FuGENE Main Business
5.6.3 FuGENE Cell therapy Processing Products, Services and Solutions
5.6.4 FuGENE Cell therapy Processing Revenue (US$ Million) & (2018-2023)
5.6.5 FuGENE Recent Developments
5.7 IBC Pharmaceuticals Inc.
5.7.1 IBC Pharmaceuticals Inc. Profile
5.7.2 IBC Pharmaceuticals Inc. Main Business
5.7.3 IBC Pharmaceuticals Inc. Cell therapy Processing Products, Services and Solutions
5.7.4 IBC Pharmaceuticals Inc. Cell therapy Processing Revenue (US$ Million) & (2018-2023)
5.7.5 IBC Pharmaceuticals Inc. Recent Developments
5.8 Bluebird Bio Inc.
5.8.1 Bluebird Bio Inc. Profile
5.8.2 Bluebird Bio Inc. Main Business
5.8.3 Bluebird Bio Inc. Cell therapy Processing Products, Services and Solutions
5.8.4 Bluebird Bio Inc. Cell therapy Processing Revenue (US$ Million) & (2018-2023)
5.8.5 Bluebird Bio Inc. Recent Developments
5.9 Immodulon-Therapeutics
5.9.1 Immodulon-Therapeutics Profile
5.9.2 Immodulon-Therapeutics Main Business
5.9.3 Immodulon-Therapeutics Cell therapy Processing Products, Services and Solutions
5.9.4 Immodulon-Therapeutics Cell therapy Processing Revenue (US$ Million) & (2018-2023)
5.9.5 Immodulon-Therapeutics Recent Developments
5.10 Immunomedics Inc.
5.10.1 Immunomedics Inc. Profile
5.10.2 Immunomedics Inc. Main Business
5.10.3 Immunomedics Inc. Cell therapy Processing Products, Services and Solutions
5.10.4 Immunomedics Inc. Cell therapy Processing Revenue (US$ Million) & (2018-2023)
5.10.5 Immunomedics Inc. Recent Developments
5.11 Juno Therapeutics Inc.
5.11.1 Juno Therapeutics Inc. Profile
5.11.2 Juno Therapeutics Inc. Main Business
5.11.3 Juno Therapeutics Inc. Cell therapy Processing Products, Services and Solutions
5.11.4 Juno Therapeutics Inc. Cell therapy Processing Revenue (US$ Million) & (2018-2023)
5.11.5 Juno Therapeutics Inc. Recent Developments
5.12 Medlmmune Inc.
5.12.1 Medlmmune Inc. Profile
5.12.2 Medlmmune Inc. Main Business
5.12.3 Medlmmune Inc. Cell therapy Processing Products, Services and Solutions
5.12.4 Medlmmune Inc. Cell therapy Processing Revenue (US$ Million) & (2018-2023)
5.12.5 Medlmmune Inc. Recent Developments
5.13 NeoStem Oncology
5.13.1 NeoStem Oncology Profile
5.13.2 NeoStem Oncology Main Business
5.13.3 NeoStem Oncology Cell therapy Processing Products, Services and Solutions
5.13.4 NeoStem Oncology Cell therapy Processing Revenue (US$ Million) & (2018-2023)
5.13.5 NeoStem Oncology Recent Developments
5.14 Neurotech USA
5.14.1 Neurotech USA Profile
5.14.2 Neurotech USA Main Business
5.14.3 Neurotech USA Cell therapy Processing Products, Services and Solutions
5.14.4 Neurotech USA Cell therapy Processing Revenue (US$ Million) & (2018-2023)
5.14.5 Neurotech USA Recent Developments
5.15 Novartis
5.15.1 Novartis Profile
5.15.2 Novartis Main Business
5.15.3 Novartis Cell therapy Processing Products, Services and Solutions
5.15.4 Novartis Cell therapy Processing Revenue (US$ Million) & (2018-2023)
5.15.5 Novartis Recent Developments
5.16 Persimmune Inc.
5.16.1 Persimmune Inc. Profile
5.16.2 Persimmune Inc. Main Business
5.16.3 Persimmune Inc. Cell therapy Processing Products, Services and Solutions
5.16.4 Persimmune Inc. Cell therapy Processing Revenue (US$ Million) & (2018-2023)
5.16.5 Persimmune Inc. Recent Developments
5.17 Pluristem Therapeutics
5.17.1 Pluristem Therapeutics Profile
5.17.2 Pluristem Therapeutics Main Business
5.17.3 Pluristem Therapeutics Cell therapy Processing Products, Services and Solutions
5.17.4 Pluristem Therapeutics Cell therapy Processing Revenue (US$ Million) & (2018-2023)
5.17.5 Pluristem Therapeutics Recent Developments
5.18 BioMed Valley Discoveries Inc.
5.18.1 BioMed Valley Discoveries Inc. Profile
5.18.2 BioMed Valley Discoveries Inc. Main Business
5.18.3 BioMed Valley Discoveries Inc. Cell therapy Processing Products, Services and Solutions
5.18.4 BioMed Valley Discoveries Inc. Cell therapy Processing Revenue (US$ Million) & (2018-2023)
5.18.5 BioMed Valley Discoveries Inc. Recent Developments
5.19 Regeneron Pharmaceuticals Inc.
5.19.1 Regeneron Pharmaceuticals Inc. Profile
5.19.2 Regeneron Pharmaceuticals Inc. Main Business
5.19.3 Regeneron Pharmaceuticals Inc. Cell therapy Processing Products, Services and Solutions
5.19.4 Regeneron Pharmaceuticals Inc. Cell therapy Processing Revenue (US$ Million) & (2018-2023)
5.19.5 Regeneron Pharmaceuticals Inc. Recent Developments
5.20 UCL Business PLC.
5.20.1 UCL Business PLC. Profile
5.20.2 UCL Business PLC. Main Business
5.20.3 UCL Business PLC. Cell therapy Processing Products, Services and Solutions
5.20.4 UCL Business PLC. Cell therapy Processing Revenue (US$ Million) & (2018-2023)
5.20.5 UCL Business PLC. Recent Developments
6 North America
6.1 North America Cell therapy Processing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Cell therapy Processing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Cell therapy Processing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Cell therapy Processing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Cell therapy Processing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Cell therapy Processing Market Dynamics
11.1 Cell therapy Processing Industry Trends
11.2 Cell therapy Processing Market Drivers
11.3 Cell therapy Processing Market Challenges
11.4 Cell therapy Processing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Industrial Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
